A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects

Short title	A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects
Status	Finished
Effective start/end date	1/03/14 → 31/08/19

Project Details